Seeking to boost its balance sheet, Arena Pharmaceuticals Inc. Friday revealed a new direct public offering of 8.95 million shares at $6.70 per share, with expected proceeds of $60 million – $30 million of which the firm plans to use to prepay a portion of a loan. (BioWorld Today) Read More
